An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating <em>PRMT7</em> expression
Shen, Ting; Ni, Ting; Chen, Jiaxuan; Chen, Haitao; Ma, Xiaopin; Cao, Guangwen; Wu, Tianzhi; Xie, Haisheng; Zhou, Bin; Wei, Gang; Saiyin, Hexige; Shen, Suqin; Yu, Peng; Xiao, Qianyi; Liu, Hui; Gao, Yuzheng; Long, Xidai; Yin, Jianhua; Guo, Yanfang; Wu, Jiaxue; Wei, Gong-Hong; Hou, Jinlin; Jiang, De-Ke (2021-03-09)
Shen, T., Ni, T., Chen, J. et al. An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression. Nat Commun 13, 1232 (2022). https://doi.org/10.1038/s41467-022-28861-0
© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
https://creativecommons.org/licenses/by/4.0/
https://urn.fi/URN:NBN:fi-fe2022051736092
Tiivistelmä
Abstract
Most cancer causal variants are found in gene regulatory elements, e.g., enhancers. However, enhancer variants predisposing to hepatocellular carcinoma (HCC) remain unreported. Here we conduct a genome-wide survey of HCC-susceptible enhancer variants through a three-stage association study in 11,958 individuals and identify rs73613962 (T > G) within the intronic region of PRMT7 at 16q22.1 as a susceptibility locus of HCC (OR = 1.41, P = 6.02 × 10⁻¹⁰). An enhancer dual-luciferase assay indicates that the rs73613962-harboring region has allele-specific enhancer activity. CRISPR-Cas9/dCas9 experiments further support the enhancer activity of this region to regulate PRMT7 expression. Mechanistically, transcription factor HNF4A binds to this enhancer region, with preference to the risk allele G, to promote PRMT7 expression. PRMT7 upregulation contributes to in vitro, in vivo, and clinical HCC-associated phenotypes, possibly by affecting the p53 signaling pathway. This concept of HCC pathogenesis may open a promising window for HCC prevention/treatment.
Kokoelmat
- Avoin saatavuus [31657]